Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Multiple Myeloma
Status:
Active, not recruiting
Trial end date:
2029-11-01
Target enrollment:
Participant gender:
Summary
The Cardamon trial is a phase 2 trial using the standard chemotherapy drugs cyclophosphamide
and dexamethasone in combination with a new drug called Carfilzomib in patients with multiple
myeloma.